Tuesday, November 17, 2009
Monday, November 16, 2009
Wednesday, November 11, 2009
Skin Whitening Reaches Market
HONG KONG--(Marketwire - 11/11/09) - Syneron Medical Ltd. (NASDAQ:ELOS - News), an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, today announced the commercial launch of the elure(TM) topical whitening products in several Asian markets.
Skin whitening is one of the fastest growing segments of the global beauty industry. The Asian market is estimated to be around US$18 billion per annum in size(1). The global whitening market is expected to grow over 10% annually(2), with major opportunities emerging from the rapidly expanding Asian markets.
The elure advanced dermal whitening product is the first scientifically proven enzymatic skin whitening treatment that targets and decomposes melanin to reveal a visibly lighter and exceptionally luminous skin tone. This product line is based on the a unique scientific discovery of a naturally occurring bio-active substance, Melanozyme(TM), working in cooperation with scientists in the field of biotechnology and enzymes and with international cosmetic experts.
Melanozyme acts to decompose the melanin in a clinically proven, fast and safe manner with no side effects. It is combined with a bio-activator to diminish the dark colored pigment in the skin. Unlike several other whitening products in the market, the elure product line does not contain Hydroquinine which may cause side effects such as skin redness and burning sensation.
Skin whitening is one of the fastest growing segments of the global beauty industry. The Asian market is estimated to be around US$18 billion per annum in size(1). The global whitening market is expected to grow over 10% annually(2), with major opportunities emerging from the rapidly expanding Asian markets.
The elure advanced dermal whitening product is the first scientifically proven enzymatic skin whitening treatment that targets and decomposes melanin to reveal a visibly lighter and exceptionally luminous skin tone. This product line is based on the a unique scientific discovery of a naturally occurring bio-active substance, Melanozyme(TM), working in cooperation with scientists in the field of biotechnology and enzymes and with international cosmetic experts.
Melanozyme acts to decompose the melanin in a clinically proven, fast and safe manner with no side effects. It is combined with a bio-activator to diminish the dark colored pigment in the skin. Unlike several other whitening products in the market, the elure product line does not contain Hydroquinine which may cause side effects such as skin redness and burning sensation.
Subscribe to:
Posts (Atom)
